Wait, we have a special
offer for you!
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full priceAlso Known as Rasilez
Only Available By Prescription
Top brand choice
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Tekturna is an oral medication primarily used to treat high blood pressure (hypertension). It falls under the category of medications called direct renin inhibitors. By targeting renin, Tekturna helps relax and widen blood vessels, which in turn reduces blood pressure. Maintaining a healthy blood pressure is crucial in preventing strokes, heart attacks, and kidney problems.
Before you buy Tekturna, make sure that you talk to your doctor about potential side effects and tekturna cost.
Take Tekturna dosage exactly as prescribed by your healthcare provider.
It's usually consumed once a day, ideally at a consistent time daily.
Tekturna can be taken with or without food. However, avoid taking it with high-fat meals as they can reduce its absorption.
Ensure you check your blood pressure regularly to monitor its effectiveness.
Continue taking Tekturna even if you feel well. Frequently, high blood pressure shows no signs.
Active Ingredient: Aliskiren
Do not use Tekturna if you are pregnant. It can harm or be fatal to your unborn baby.
Consult your doctor if you have a history of kidney problems, diabetes, or high levels of potassium in your blood.
Avoid using potassium supplements or salt substitutes unless your doctor has told you to.
If you experience symptoms of a high potassium level (slow or irregular heartbeat, muscle weakness), contact your doctor immediately.
Tekturna may interact with other medications, including ACE inhibitors, ARBs, potassium-sparing diuretics, and NSAIDs. Avoid alcohol as it can further lower your blood pressure and increase side effects.
Common side effects of Tekturna include:
Remember, these are not exhaustive lists, and it's important to consult with a healthcare professional for personalized advice and guidance. If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088
Can Tekturna be cut in half?
It is essential to take Tekturna as prescribed. If you struggle with taking the tablet, seek advice from your medical professional. Do not cut, crush, or chew the tablet unless directed by a physician.
How much does Tekturna cost?
The cost of Tekturna can vary based on location, pharmacy, and insurance coverage. You can buy Tekturna online from CanPharm and pay the most reasonable price.
Is Tekturna a beta blocker?
No, Tekturna is not a beta blocker. It is a direct renin inhibitor. While both classes of drugs are used to treat high blood pressure, they work in different ways.
Is there a generic for Tekturna?
Yes, there is a generic version of Tekturna available, known by its active ingredient, Aliskiren.
Why are Tekturna tablets dispensed in its original container?
Tekturna tablets are dispensed in their original container to protect them from moisture and light, ensuring their efficacy and stability. Always store in the original container and keep the container tightly closed.
